{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:22:01Z","timestamp":1767705721738,"version":"3.37.3"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Wenzhou Medical University Affiliated Second Hospital, Yuying Children's Hospital Doctoral Research Startup Fund Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10620-023-08175-x","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T16:03:22Z","timestamp":1704297802000},"page":"491-501","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interferon-Gamma-Inducible Protein 16 Inhibits Hepatocellular Carcinoma via Interferon Regulatory Factor 3 on Chemosensitivity"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-4406-3830","authenticated-orcid":false,"given":"Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonglin","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peipei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"ZhuGe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanghong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"8175_CR1","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, de Martel C et al. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer 2022;161:108\u2013118.","journal-title":"Eur J Cancer"},{"key":"8175_CR2","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","volume":"77","author":"AG Singal","year":"2022","unstructured":"Singal AG, Zhang E, Narasimman M et al. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis. J Hepatol 2022;77:128\u2013139.","journal-title":"J Hepatol"},{"key":"8175_CR3","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","volume":"28","author":"AX Zhu","year":"2022","unstructured":"Zhu AX, Abbas AR, de Galarreta MR et al. Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma. Nat Med 2022;28:1599\u20131611.","journal-title":"Nat Med"},{"key":"8175_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ymthe.2021.08.027","volume":"30","author":"P Li","year":"2022","unstructured":"Li P, Song R, Yin F et al. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma. Mol Ther 2022;30:431\u2013447.","journal-title":"Mol Ther"},{"key":"8175_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/s13046-022-02526-8","volume":"41","author":"Z Gao","year":"2022","unstructured":"Gao Z, Xu J, Fan Y et al. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells. J Exp Clin Cancer Res 2022;41:323.","journal-title":"J Exp Clin Cancer Res"},{"key":"8175_CR6","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1126\/sciadv.abg6680","volume":"7","author":"JL Justice","year":"2021","unstructured":"Justice JL, Kennedy MA, Hutton JE et al. Systematic profiling of protein complex dynamics reveals DNA-PK phosphorylation of IFI16 en route to herpesvirus immunity. Sci Adv 2021;7:6680.","journal-title":"Sci Adv"},{"key":"8175_CR7","doi-asserted-by":"publisher","first-page":"E3008","DOI":"10.1073\/pnas.1211302109","volume":"109","author":"MH Orzalli","year":"2012","unstructured":"Orzalli MH, DeLuca NA, Knipe DM. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A 2012;109:E3008\u2013E3017.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8175_CR8","doi-asserted-by":"publisher","first-page":"8931","DOI":"10.1038\/sj.onc.1207057","volume":"22","author":"JA Aglipay","year":"2003","unstructured":"Aglipay JA, Lee SW, Okada S et al. A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway. Oncogene 2003;22:8931\u20138938.","journal-title":"Oncogene"},{"key":"8175_CR9","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.molimm.2011.11.004","volume":"49","author":"S Veeranki","year":"2012","unstructured":"Veeranki S, Choubey D. Interferon-inducible p200-family protein IFI16, an innate immune sensor for cytosolic and nuclear double-stranded DNA: regulation of subcellular localization. Mol Immunol 2012;49:567\u2013571.","journal-title":"Mol Immunol"},{"key":"8175_CR10","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1158\/1541-7786.MCR-06-0269","volume":"5","author":"F Alimirah","year":"2007","unstructured":"Alimirah F, Chen J, Davis FJ, Choubey D. IFI16 in human prostate cancer. Mol Cancer Res 2007;5:251\u2013259.","journal-title":"Mol Cancer Res"},{"key":"8175_CR11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/apm.12692","volume":"125","author":"PP Piccaluga","year":"2017","unstructured":"Piccaluga PP, Agostinelli C, Righi S et al. IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia. APMIS 2017;125:511\u2013522.","journal-title":"APMIS"},{"key":"8175_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2559.2004.02000.x","volume":"45","author":"B Azzimonti","year":"2004","unstructured":"Azzimonti B, Pagano M, Mondini M et al. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index. Histopathology 2004;45:560\u2013572.","journal-title":"Histopathology"},{"key":"8175_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110138","volume":"37","author":"NL Ka","year":"2021","unstructured":"Ka NL, Lim GY, Hwang S, Kim SS, Lee MO. IFI16 inhibits DNA repair that potentiates type-I interferon-induced antitumor effects in triple negative breast cancer. Cell Rep 2021;37:110138.","journal-title":"Cell Rep"},{"key":"8175_CR14","doi-asserted-by":"publisher","first-page":"49944","DOI":"10.18632\/oncotarget.18278","volume":"8","author":"R Januchowski","year":"2017","unstructured":"Januchowski R, Sterzynska K, Zawierucha P et al. Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell lines. Oncotarget 2017;8:49944\u201349958.","journal-title":"Oncotarget"},{"key":"8175_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113036","volume":"150","author":"J Borucka","year":"2022","unstructured":"Borucka J, Sterzynska K, Kazmierczak D et al. The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines. Biomed Pharmacother 2022;150:113036.","journal-title":"Biomed Pharmacother"},{"key":"8175_CR16","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.18632\/oncotarget.6480","volume":"7","author":"M Kikuchi","year":"2016","unstructured":"Kikuchi M, Yamashita K, Waraya M et al. Epigenetic regulation of ZEB1-RAB25\/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer. Oncotarget 2016;7:1741\u20131753.","journal-title":"Oncotarget"},{"key":"8175_CR17","doi-asserted-by":"publisher","first-page":"29328","DOI":"10.18632\/oncotarget.16440","volume":"8","author":"H Ma","year":"2017","unstructured":"Ma H, Li L, Dou G et al. Z-ligustilide restores tamoxifen sensitivity of ERa negative breast cancer cells by reversing MTA1\/IFI16\/HDACs complex mediated epigenetic repression of ERa. Oncotarget 2017;8:29328\u201329345.","journal-title":"Oncotarget"},{"key":"8175_CR18","doi-asserted-by":"publisher","first-page":"e12392","DOI":"10.1111\/cpr.12392","volume":"50","author":"W Lin","year":"2017","unstructured":"Lin W, Zhao Z, Ni Z, Zhao Y, Du W, Chen S. IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome. Cell Prolif 2017;50:e12392.","journal-title":"Cell Prolif"},{"key":"8175_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1200\/JCO.21.01467","volume":"40","author":"XY Li","year":"2022","unstructured":"Li XY, Luo DH, Guo L et al. Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial. J Clin Oncol 2022;40:1163\u20131173.","journal-title":"J Clin Oncol"},{"key":"8175_CR20","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.3390\/cancers6031769","volume":"6","author":"G Housman","year":"2014","unstructured":"Housman G, Byler S, Heerboth S et al. Drug resistance in cancer: an overview. Cancers (Basel) 2014;6:1769\u20131792.","journal-title":"Cancers (Basel)"},{"key":"8175_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02643","volume":"5","author":"PP Piccaluga","year":"2019","unstructured":"Piccaluga PP, Navari M, Visani A et al. Interferon gamma inducible protein 16 (IFI16) expression is reduced in mantle cell lymphoma. Heliyon 2019;5:e02643.","journal-title":"Heliyon"},{"key":"8175_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100930","volume":"297","author":"D Li","year":"2021","unstructured":"Li D, Xie L, Qiao Z et al. STING-mediated degradation of IFI16 negatively regulates apoptosis by inhibiting p53 phosphorylation at serine 392. J Biol Chem 2021;297:100930.","journal-title":"J Biol Chem"},{"key":"8175_CR23","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1074\/jbc.M410542200","volume":"280","author":"EJ Kim","year":"2005","unstructured":"Kim EJ, Park JI, Nelkin BD. IFI16 is an essential mediator of growth inhibition, but not differentiation, induced by the leukemia inhibitory factor\/JAK\/STAT pathway in medullary thyroid carcinoma cells. J Biol Chem 2005;280:4913\u20134920.","journal-title":"J Biol Chem"},{"key":"8175_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12935-022-02496-z","volume":"22","author":"Y Wang","year":"2022","unstructured":"Wang Y, Yang L, Mao L et al. SGLT2 inhibition restrains thyroid cancer growth via G1\/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways. Cancer Cell Int 2022;22:74.","journal-title":"Cancer Cell Int"},{"key":"8175_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/cancers11070905","volume":"11","author":"E Berthel","year":"2019","unstructured":"Berthel E, Foray N, Ferlazzo ML. The Nucleoshuttling of the ATM Protein: A Unified Model to Describe the Individual Response to High- and Low-Dose of Radiation? Cancers (Basel) 2019;11:905.","journal-title":"Cancers (Basel)"},{"key":"8175_CR26","doi-asserted-by":"publisher","first-page":"5678","DOI":"10.1093\/nar\/gkn550","volume":"36","author":"A Kinner","year":"2008","unstructured":"Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 2008;36:5678\u20135694.","journal-title":"Nucleic Acids Res"},{"key":"8175_CR27","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1002\/ijc.25953","volume":"129","author":"EC Bourton","year":"2011","unstructured":"Bourton EC, Plowman PN, Smith D, Arlett CF, Parris CN. Prolonged expression of the \u03b3-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatment. Int J Cancer 2011;129:2928\u20132934.","journal-title":"Int J Cancer"},{"issue":"1","key":"8175_CR28","first-page":"E384","volume":"38","author":"JJ Ko","year":"2016","unstructured":"Ko JJ, Klimowicz AC, Jagdis A et al. ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent. Head Neck 2016;38(1):E384\u2013E391.","journal-title":"Head Neck"},{"key":"8175_CR29","doi-asserted-by":"publisher","first-page":"4867","DOI":"10.1002\/jcb.26699","volume":"119","author":"FJ Romano","year":"2018","unstructured":"Romano FJ, Guadagno E, Solari D et al. ATM and p53 combined analysis predicts survival in glioblastoma multiforme patients: A clinicopathologic study. J Cell Biochem 2018;119:4867\u20134877.","journal-title":"J Cell Biochem"},{"key":"8175_CR30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.radonc.2013.06.022","volume":"108","author":"U Koch","year":"2013","unstructured":"Koch U, H\u00f6hne K, von Neubeck C et al. Residual \u03b3H2AX foci predict local tumour control after radiotherapy. Radiother Oncol 2013;108:434\u2013439.","journal-title":"Radiother Oncol"},{"key":"8175_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13020-020-00340-y","volume":"15","author":"X Shi","year":"2020","unstructured":"Shi X, Li S, Wang L et al. RalB degradation by dihydroartemisinin induces autophagy and IFI16\/caspase-1 inflammasome depression in the human laryngeal squamous cell carcinoma. Chin Med 2020;15:64.","journal-title":"Chin Med"},{"key":"8175_CR32","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/hed.20611","volume":"29","author":"M De Andrea","year":"2007","unstructured":"De Andrea M, Gioia D, Mondini M et al. Effects of IFI16 overexpression on the growth and doxorubicin sensitivity of head and neck squamous cell carcinoma-derived cell lines. Head Neck 2007;29:835\u2013844.","journal-title":"Head Neck"},{"key":"8175_CR33","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2201376119","volume":"119","author":"LT Ong","year":"2022","unstructured":"Ong LT, Lee WC, Ma S et al. IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer. Proc Natl Acad Sci U S A 2022;119:e2201376119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8175_CR34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20171116","volume":"215","author":"S Jiao","year":"2018","unstructured":"Jiao S, Guan J, Chen M et al. Targeting IRF3 as a YAP agonist therapy against gastric cancer. J Exp Med 2018;215:699\u2013718.","journal-title":"J Exp Med"},{"key":"8175_CR35","doi-asserted-by":"publisher","first-page":"BSR20202603","DOI":"10.1042\/BSR20202603","volume":"40","author":"Z Qi","year":"2020","unstructured":"Qi Z, Yan F, Chen D et al. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma. Biosci Rep 2020;40:BSR20202603.","journal-title":"Biosci Rep"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08175-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-08175-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-08175-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T18:22:35Z","timestamp":1707762155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-08175-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["8175"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-08175-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"type":"print","value":"0163-2116"},{"type":"electronic","value":"1573-2568"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving animals were in accordance with the ethical standards of the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}